bitter melon extract: Clinical Trials

5 trials of bitter melon extract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 unknown. 3 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Not yet recruiting 1, Unknown 1
Phase 22Completed 2

Follow bitter melon extract: new trials by email Literature Review of bitter melon extract trials Research Report on bitter melon extract

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Bitter Melon Extract and Snakehead Fish Powder Supplementation for Glycemic Control in Type 2 Diabetes
Snakehead Fish Powder + Bitter Melon Extract, Placebo Capsule - Type 2 Diabetes Mellitus (T2DM), Hyperglycemia
Not applicableNot yet recruitingUniversitas Muhammadiyah Surakarta802026-01-012025-12-24
Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency
Dihydroartemisinin, Piperaquine, Primaquine - Uncomplicated Plasmodium Falciparum
Phase 2CompletedSyamsudin Abdillah,Ph.D, Pharm D362022-11-012023-05-16
Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes Mellitus
Bitter Melon Extract and Snakehead Fish Powder Combination, Placebo Capsule - Type 2 Diabetes Mellitus (T2DM)
Not applicableCompletedUniversitas Muhammadiyah Surakarta802021-06-012025-12-24
Effect of Momordica Charantia Administration on Anthropometric Indicators in Patients With Obesity
Momordica charantia, Placebo - Obesity
Not applicableUnknownUniversity of Guadalajara242020-01-212021-08-31
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
Dihydroartemisinin, Piperaquine, Primaquine - Malaria,Falciparum, Malaria, Vivax
Phase 2CompletedSyamsudin Abdillah,Ph.D, Pharm D502019-01-112023-09-13

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Hyperglycemia (1)  ·  Infections (1)  ·  Malaria (1)  ·  Malaria, Falciparum (1)  ·  Malaria, Vivax (1)  ·  Obesity (1)

Sponsors

Syamsudin Abdillah,Ph.D, Pharm D (2)  ·  Universitas Muhammadiyah Surakarta (2)  ·  University of Guadalajara (1)

Countries

Indonesia (3)  ·  Mexico (1)

Top investigators

Marisol Cortez Navarrete, PhD (1)

Results publications

PMID 26654101, PMID 35507955